Xtl Biopharmaceuticals (XTLB) Short-term Investments (2009 - 2025)
Xtl Biopharmaceuticals (XTLB) reported Short-term Investments of $109,000 for the quarter ended Jun 30, 2025, down 89.0% from $992,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Short-term Investments (2009 - 2025) Analysis & Trends
As of Dec 31, 2024, Xtl Biopharmaceuticals posted Short-term Investments of $772,000, up 27.6% from the prior year.
- Short-term Investments has a five-year compound annual growth rate of -19.4% (years ended Dec 2019 to Dec 2024).
- By year, Short-term Investments came in at $605,000 in the year ended Dec 31, 2023 (-62.8%), $1.63 million in the year ended Dec 31, 2022 (-48.5%), $3.16 million in the year ended Dec 31, 2021 (+31.0%) and $2.41 million in the year ended Dec 31, 2020 (+6.1%).
- The figure for the quarter ended Jun 30, 2025 ranks as the lowest quarterly Short-term Investments since the quarter ended Dec 31, 2009.
- Year over year, Short-term Investments gained in four of the last seven quarters, with an average decline of 16.2%.
- The high point for year-over-year Short-term Investments in five years was the quarter ended Dec 31, 2021 (growth of 31.0%); the low point was the quarter ended Jun 30, 2025 (a decline of 89.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Xtl Biopharmaceuticals | 2.27 Bn | 2.27 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 109,000.00 |
| Dec 31, 2024 | 772,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 992,000.00 |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 605,000.00 |
| Sep 30, 2023 | 749,000.00 |
| Jun 30, 2023 | 794,000.00 |
| Mar 31, 2023 | 972,000.00 |
| Dec 31, 2022 | 1.63 Mn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 2.81 Mn |
| Dec 31, 2021 | 3.16 Mn |
| Jun 30, 2021 | 3.38 Mn |
| Dec 31, 2020 | 2.41 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Dec 31, 2018 | 2.85 Mn |
| Sep 30, 2018 | 4.33 Mn |
| Jun 30, 2018 | 4.32 Mn |
| Mar 31, 2018 | 4.52 Mn |
API Access
Xtl Biopharmaceuticals Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();